CIAS
AZN icon

Capital Investment Advisory Services’s AstraZeneca AZN Stock Holding History

Capital Investment Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Sell
1,845
-72
-4% -$13.5K 0.02% 536
2026
Q1 		$378K Buy
1,917
+56
+3% +$10.8K 0.03% 457
2025
Q4 		$342K Buy
1,861
+138
+8% +$24.2K 0.02% 469
2025
Q3 		$264K Buy
1,723
+38
+2% +$5.75K 0.02% 507
2025
Q2 		$236K Sell
1,685
-172
-9% -$24.1K 0.02% 515
2025
Q1 		$273K Buy
1,857
+196
+12% +$28.4K 0.02% 460
2024
Q4 		$218K Sell
1,661
-603
-27% -$84.4K 0.02% 472
2024
Q3 		$353K Sell
2,264
-9
-0.4% -$1.45K 0.03% 377
2024
Q2 		$354K Buy
2,273
+25
+1% +$3.76K 0.04% 357
2024
Q1 		$305K Sell
2,248
-566
-20% -$74.9K 0.03% 398
2023
Q4 		$379K Sell
2,814
-688
-20% -$89.4K 0.04% 356
2023
Q3 		$474K Buy
3,502
+707
+25% +$96.6K 0.05% 287
2023
Q2 		$400K Sell
2,795
-171
-6% -$25.2K 0.04% 313
2023
Q1 		$412K Sell
2,966
-195
-6% -$26.2K 0.05% 297
2022
Q4 		$429K Sell
3,161
-597
-16% -$74.9K 0.05% 300
2022
Q3 		$412K Sell
3,758
-95
-2% -$12.1K 0.05% 286
2022
Q2 		$509K Buy
3,853
+169
+5% +$22.2K 0.06% 257
2022
Q1 		$489K Sell
3,684
-524
-12% -$62.8K 0.05% 287
2021
Q4 		$490K Sell
4,208
-142
-3% -$16.7K 0.06% 276
2021
Q3 		$522K Sell
4,350
-3,504
-45% -$408K 0.07% 256
2021
Q2 		$941K Sell
7,854
-2,547
-24% -$279K 0.12% 170
2021
Q1 		$1.03M Sell
10,401
-3,751
-27% -$377K 0.15% 143
2020
Q4 		$1.42M Sell
14,152
-12
-0.1% -$1.27K 0.21% 106
2020
Q3 		$1.55M Buy
14,164
+50
+0.4% +$5.56K 0.29% 81
2020
Q2 		$1.49M Buy
14,114
+46
+0.3% +$4.75K 0.3% 79
2020
Q1 		$1.26M Buy
+14,068
New +$1.32M 0.31% 72
2019
Q4 		– Sell
-1,420
Closed -$127K – 602
2019
Q3 		$127K Buy
1,420
+70
+5% +$6.07K 0.04% 339
2019
Q2 		$109K Buy
1,350
+250
+23% +$19.6K 0.03% 368
2019
Q1 		$89K Hold
1,100
– – 0.03% 365
2018
Q4 		$84K Buy
+1,100
New +$85.9K 0.04% 341

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Capital Investment Advisory Services's AZN Position: Q2 2026 in Review

Capital Investment Advisory Services reduced its AstraZeneca (AZN) stake by 3.8% in Q2 2026, selling an estimated $13.5K and leaving 1,845 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #536.

Capital Investment Advisory Services first reported a position in AZN in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.55M in Q3 2020. 472 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Capital Investment Advisory Services held 1,845 shares of AstraZeneca worth $350K as of Q2 2026.
  • Capital Investment Advisory Services sold 72 AstraZeneca shares in Q2 2026, an estimated $13.5K.
  • AstraZeneca made up 0.02% of Capital Investment Advisory Services's portfolio in Q2 2026, its #536 holding.
  • Capital Investment Advisory Services first reported a position in AstraZeneca in Q4 2018 and has held it in 30 quarters since.
  • Capital Investment Advisory Services's AstraZeneca position peaked at $1.55M in Q3 2020.
  • 472 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.